Mark Korpics to Combined Modality Therapy
This is a "connection" page, showing publications Mark Korpics has written about Combined Modality Therapy.
Connection Strength
0.212
-
A Validated T Cell Radiomics Score Is Associated With Clinical Outcomes Following Multisite SBRT and Pembrolizumab. Int J Radiat Oncol Biol Phys. 2020 09 01; 108(1):189-195.
Score: 0.134
-
Safety of combined ablative radiotherapy and immune checkpoint inhibitors in three phase I trials. Eur J Cancer. 2024 Sep; 209:114264.
Score: 0.045
-
Proceedings of the ASTRO-RSNA Oligometastatic Disease Research Workshop. Int J Radiat Oncol Biol Phys. 2020 11 01; 108(3):539-545.
Score: 0.033